CVRx Reiterates Plans to Discuss the Preliminary Results from the Post-Market Phase of the BeAT-HF Trial at THT 2023 and Schedules a Conference Call

MINNEAPOLIS, March 16, 2023 -- CVRx, Inc. , a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular... | March 16, 2023

Related Keywords

Boston ,Massachusetts ,United States ,Laura Oneill ,Mike Vallie ,Michael Zile ,Mark Klausner ,University Of South Carolina ,Globenewswire Inc ,Cvrx Inc ,Heart Failure Therapeutics ,Eastern Time ,South Carolina ,Activation Therapy ,New Insights ,European Economic ,Cvrx ,Nc Stock Exchange ,News ,Information ,Press Release ,Arch ,023 ,Medical ,Device ,Company ,Ocused ,N ,Manufacturing ,End ,Commercializing ,Nnovative Cvrx Us1266381052 ,